These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2757794)
1. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten. Reitermann A; Metzger J; Wiesmüller KH; Jung G; Bessler WG Biol Chem Hoppe Seyler; 1989 Apr; 370(4):343-52. PubMed ID: 2757794 [TBL] [Abstract][Full Text] [Related]
2. The influence of various adjuvants on antibody synthesis following immunization with an hapten. Kellner J; Erhard M; Schranner I; Lösch U Biol Chem Hoppe Seyler; 1992 Jan; 373(1):51-5. PubMed ID: 1536694 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Metzger J; Wiesmüller KH; Schaude R; Bessler WG; Jung G Int J Pept Protein Res; 1991 Jan; 37(1):46-57. PubMed ID: 2045219 [TBL] [Abstract][Full Text] [Related]
4. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides. Seifert R; Schultz G; Richter-Freund M; Metzger J; Wiesmüller KH; Jung G; Bessler WG; Hauschildt S Biochem J; 1990 May; 267(3):795-802. PubMed ID: 2160237 [TBL] [Abstract][Full Text] [Related]
5. Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells. Offermanns S; Seifert R; Metzger JW; Jung G; Lieberknecht A; Schmidt U; Schultz G Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):551-7. PubMed ID: 1312332 [TBL] [Abstract][Full Text] [Related]
6. Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro. Metzger J; Jung G; Bessler WG; Hoffmann P; Strecker M; Lieberknecht A; Schmidt U J Med Chem; 1991 Jul; 34(7):1969-74. PubMed ID: 2066969 [TBL] [Abstract][Full Text] [Related]
7. Synthetic lipopeptides as novel adjuvants. Bessler WG; Jung G Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136 [TBL] [Abstract][Full Text] [Related]
8. Preparation of human and murine monoclonal antibodies: antigens combined with or conjugated to lipopeptides constitute potent immunogens for in vitro and in vivo immunizations. Hoffmann P; Jimenez-Diaz M; Loleit M; Tröger W; Wiesmüller KH; Metzger J; Jung G; Kaiser I; Stöcklin S; Lenzner S Hum Antibodies Hybridomas; 1990; 1(3):137-44. PubMed ID: 2103357 [TBL] [Abstract][Full Text] [Related]
9. Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope. Hoffmann P; Loleit M; Mittenbühler K; Beck W; Wiesmüller KH; Jung G; Bessler WG FEMS Immunol Med Microbiol; 1997 Apr; 17(4):225-34. PubMed ID: 9143880 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes. Roth A; Espuelas S; Thumann C; Frisch B; Schuber F Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182 [TBL] [Abstract][Full Text] [Related]
11. Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Bessler WG; Suhr B; Bühring HJ; Muller CP; Wiesmüller KH; Becker G; Jung G Immunobiology; 1985 Sep; 170(3):239-44. PubMed ID: 4054942 [TBL] [Abstract][Full Text] [Related]
12. Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization. Loleit M; Deres K; Wiesmüller KH; Jung G; Eckert M; Bessler WG Biol Chem Hoppe Seyler; 1994 Jun; 375(6):407-12. PubMed ID: 7980873 [TBL] [Abstract][Full Text] [Related]
13. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro. Mittenbühler K; Loleit M; Baier W; Fischer B; Sedelmeier E; Jung G; Winkelmann G; Jacobi C; Weckesser J; Erhard MH; Hofmann A; Bessler W; Hoffmann P Int J Immunopharmacol; 1997 May; 19(5):277-87. PubMed ID: 9439766 [TBL] [Abstract][Full Text] [Related]
14. Alteration of the lateral organization of the plasma membrane of Chinese hamster ovary cells by synthetic lipopeptide, Pam3Cys-Ser-Lys4. Vergne I; Cézanne L Eur J Biochem; 1999 Sep; 264(2):369-73. PubMed ID: 10491081 [TBL] [Abstract][Full Text] [Related]
15. Lipopeptide adjuvants in combination treatment. Bessler WG; Mittenbühler K; Esche Uv; Huber M Int Immunopharmacol; 2003 Aug; 3(8):1217-24. PubMed ID: 12860177 [TBL] [Abstract][Full Text] [Related]
16. Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues. Hoffmann P; Wiesmüller KH; Metzger J; Jung G; Bessler WG Biol Chem Hoppe Seyler; 1989 Jun; 370(6):575-82. PubMed ID: 2775484 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant effects of various lipopeptides and interferon-gamma on the humoral immune response of chickens. Erhard MH; Schmidt P; Zinsmeister P; Hofmann A; Münster U; Kaspers B; Wiesmüller KH; Bessler WG; Stangassinger M Poult Sci; 2000 Sep; 79(9):1264-70. PubMed ID: 11020070 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable microspheres. XIII: Immune response to the DNP hapten conjugated to polyacryl starch microparticles. Stjärnkvist P; Degling L; Sjöholm I J Pharm Sci; 1991 May; 80(5):436-40. PubMed ID: 1880722 [TBL] [Abstract][Full Text] [Related]